Overview

A Study of the Safety and Efficacy of Infliximab (Remicade) in Subjects With Fistulizing Crohn's Disease

Status:
Completed
Trial end date:
2006-08-01
Target enrollment:
Participant gender:
Summary
A study of infliximab in patients with Fistulizing Crohn's Disease
Phase:
Phase 3
Details
Lead Sponsor:
Centocor, Inc.
Treatments:
Infliximab